Solid Form Composition for Use in Treatment of Extraoesophageal Symptoms of Gastric Reflux
Summary
The European Patent Office published patent application EP3752202A1 filed by Drugs Minerals and Generics Italia S.R.L. for a solid dosage form composition intended for treating extraoesophageal symptoms of gastric reflux. The application, filed with inventor Luigi Mercuri, designates multiple EU member states including DE, FR, GB, IT, ES, NL, and 24 others. This publication establishes a priority date for the claimed pharmaceutical composition.
What changed
The EPO published patent application EP3752202A1 for a solid form pharmaceutical composition designed for treating extraoesophageal symptoms associated with gastric reflux. The application claims a composition under IPC classifications A61K 47/36, A61K 47/44, A61K 9/16, and A61K 9/20.
For pharmaceutical manufacturers and drug developers, this publication establishes a priority date for potential claims in the solid dosage formulation space for extraoesophageal reflux treatments. Competitors developing similar formulations should conduct freedom-to-operate analyses and monitor the prosecution of this application through the EPO examination process.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION IN SOLID FORM FOR USE IN THE TREATMENT OF EXTRAOESOPHAGEAL SYMPTOMS OF GASTRIC REFLUX
Publication EP3752202A1 Kind: A1 Apr 08, 2026
Applicants
Drugs Minerals and Generics Italia S.R.L.
In Forma Abbreviata D.M.G. Italia S.R.L.
Inventors
MERCURI, Luigi
IPC Classifications
A61K 47/36 20060101AFI20190823BHEP A61K 47/44 20170101ALI20190823BHEP A61K 9/16 20060101ALI20190823BHEP A61K 9/20 20060101ALI20190823BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.